JMJD3 regulates the M2-like macrophage polarization and promotes the growth of breast cancer cells via STAT6/IRF4 axis
PLOS One · 2026
DOI: 10.1371/journal.pone.0341313 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Juan Lyu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shaoxing People's Hospital, Shaoxing, Zhejiang, P.R. China. Hauptthemen laut MEDLINE: STAT6 Transcription Factor, Jumonji Domain-Containing Histone Demethylases, Interferon Regulatory Factors, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Medical Science and Technology Project of Zhejiang Province, Shaoxing City Health Science and Technology Plan.
Abstract (Originalsprache)
M2-like macrophages play a critical role in breast cancer progression. Although JMJD3 is reported to play a significant role in M2-like macrophage polarization, its precise mechanism remains unclear. By using PMA, IL-4, and IL-13, we successfully induced THP-1 cells into M2-like macrophages, which subsequently promoted breast cancer cell proliferation and inhibited apoptosis, accompanied by increased JMJD3 expression. We demonstrated that JMJD3 enhances M2-like macrophage polarization: knockdown of JMJD3 decreased the M2-like macrophage gene expression, while overexpression of JMJD3 produced the opposite effects. Furthermore, JMJD3 promoted M2-like macrophage polarization through the STAT6/IRF4 axis. Knockdown of JMJD3 abrogated IL-4/IL-13 induced IRF4 expression, while overexpression of JMJD3 upregulated IRF4 expression. Inhibition of STAT6 downregulated the expression of JMJD3, IRF4, and M2-like macrophage marker genes. Additionally, inhibiting JMJD3 and STAT6 in macrophages increased cell apoptosis and decreased cell viability in breast cancer cells, while JMJD3 overexpression exhibited pro-tumor activity. In conclusion, our findings highlight the role of JMJD3 in regulating M2-like macrophage polarization and its impact on breast cancer development through the STAT6/IRF4 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shaoxing People's Hospital, Shaoxing, Zhejiang, P.R. China.
- School of Medicine, Shaoxing University, Shaoxing, Zhejiang, P.R. China.
- Department of pathology, Wuchuan County People's Hospital, Zunyi, Guizhou, P.R. China.
ORCID-Profile: Juan Lyu, Lihong Zhang
Förderung
- Natural Science Foundation of Zhejiang Province
- Medical Science and Technology Project of Zhejiang Province
- Shaoxing City Health Science and Technology Plan
Zitieren
APA
Lyu, J., Wang, E., Lyu, S., Qian, Y., Ye, F., Xu, X., Wang, Q., Lu, T., Hu, L., Xu, H., & Zhang, L. (2026). JMJD3 regulates the M2-like macrophage polarization and promotes the growth of breast cancer cells via STAT6/IRF4 axis. PLOS One. https://doi.org/10.1371/journal.pone.0341313
Vancouver
Lyu J, Wang E, Lyu S, Qian Y, Ye F, Xu X, et al. JMJD3 regulates the M2-like macrophage polarization and promotes the growth of breast cancer cells via STAT6/IRF4 axis. PLOS One. 2026. doi:10.1371/journal.pone.0341313
BibTeX
@article{Lyu2026,
author = {Lyu, Juan and Wang, Enqin and Lyu, Shanmei and Qian, Ying and Ye, Fen and Xu, Xiuping and Wang, Qing and Lu, Tao and Hu, Liangfeng and Xu, Hongkun and Zhang, Lihong},
title = {JMJD3 regulates the M2-like macrophage polarization and promotes the growth of breast cancer cells via STAT6/IRF4 axis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341313}
}
EUVIMED